Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 May;24(2):565–566. doi: 10.1128/iai.24.2.565-566.1979

Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.

E Yarkoni, L Peters, H J Rapp, M G Hanna, J T Hunter
PMCID: PMC414338  PMID: 378859

Abstract

Emulsified cell walls of Mycobacterium bovis (BCG) were immunotherapeutically at least as active as living BCG in prolonging survival of guinea pigs with established dermal tumors and microscopic lymph node and visceral metastases.

Full text

PDF
565

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gutterman J. U., Mavligit G., McBride C., Frei E., 3rd, Freireich E. J., Hersh E. M. Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet. 1973 Jun 2;1(7814):1208–1212. doi: 10.1016/s0140-6736(73)90526-6. [DOI] [PubMed] [Google Scholar]
  2. Gutterman J. U., Mavligit G., McBride C., Frei E., 3rd, Hersh E. M. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule. Natl Cancer Inst Monogr. 1973 Dec;39:205–212. [PubMed] [Google Scholar]
  3. McKneally M. F., Maver C., Kausel H. W. Regional immunotherapy of lung cancer with intrapleural B.C.G. Lancet. 1976 Feb 21;1(7956):377–379. doi: 10.1016/s0140-6736(76)90212-9. [DOI] [PubMed] [Google Scholar]
  4. Morton D. L., Eilber F. R., Joseph W. L., Wood W. C., Trahan E., Ketcham A. S. Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann Surg. 1970 Oct;172(4):740–749. doi: 10.1097/00000658-197010000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Pinsky C. M., Hirshaut Y., Oettgen H. F. Treatment of malignant melanoma by intratumoral injection of BCG. Natl Cancer Inst Monogr. 1973 Dec;39:225–228. [PubMed] [Google Scholar]
  6. Rapp H. J. A guinea pig model for tumor immunology. A summary. Isr J Med Sci. 1973 Mar;9(3):366–374. [PubMed] [Google Scholar]
  7. Rosenberg S. A., Seipp C., Sears H. F. Clinical and immunologic studies of disseminated BCG infection. Cancer. 1978 May;41(5):1771–1780. doi: 10.1002/1097-0142(197805)41:5<1771::aid-cncr2820410519>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  8. Seiger H. F., Shingleton W. W., Metzgar R. S., Buckley C. E., 3rd Immunotherapy in patients with melanoma. Ann Surg. 1973 Sep;178(3):352–359. doi: 10.1097/00000658-197309000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Zbar B., Ribi E., Meyer T., Azuma I., Rapp H. J. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets. J Natl Cancer Inst. 1974 May;52(5):1571–1577. doi: 10.1093/jnci/52.5.1571. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES